Home > Clinical Trials

Saved trials

NOT_YET_RECRUITING
NCT07619365
Trastuzumab Deruxtecan and Lovastatin in HER2-low and Ultralow Advanced or Metastatic Breast Cancer
60 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
Breast Cancer


Advanced Breast Cancer


Metastatic Breast Cancer
RECRUITING
NCT02693535
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
4,200 Enrollment(s)
181 Study location(s)
INTERVENTIONAL (PHASE2)
Lymphoma, Non-Hodgkin


Multiple Myeloma


Advanced Solid Tumors
RECRUITING
NCT05274048
Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients
18 Enrollment(s)
3 Study location(s)
INTERVENTIONAL (PHASE1)
Gastric Cancer


Gastrointestinal Cancer


HER2 Gene Mutation
RECRUITING
NCT06769490
Dose Escalation and Expansion of Ziftomenib in Combination With Quizartinib in Acute Myeloid Leukemia
44 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE1)
Acute Myeloid Leukemia
NOT_YET_RECRUITING
NCT07825753
Protein-Matched ADC or PDC Umbrella Trial in Advanced Pancreatic and Breast Cancer
225 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
Advanced or Metastatic Pancreatic Adenocarcinoma


Advanced or Metastatic Breast Cancer (BC)
RECRUITING
NCT06824168
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
130 Enrollment(s)
64 Study location(s)
INTERVENTIONAL (PHASE2)
Acute Myeloid Leukemia


Leukemia
RECRUITING
NCT07678957
A Study Comparing BL-M07D1 With DS-8201 in Patients With HR-Positive, HER2-Low Expressing Recurrent/Metastatic Breast Cancer
120 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
Breast Cancer
RECRUITING
NCT06727227
Real-world Study of Trastuzumab Deruxtecan in Patients With Unresectable or Metastatic HER2-low Breast Cancer
138 Enrollment(s)
14 Study location(s)
OBSERVATIONAL (None)
Breast Cancer